Leukaemia: Drugs
(asked on 1st December 2017) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, when the ATIR treatment for people with leukaemia will be available on the NHS.
This question was answered on 11th December 2017
The National Institute for Health and Care Excellence (NICE) has been asked to develop technology appraisal guidance on the use of ATIR101 to support haematopoietic stem cell transplantation using partially mismatched (haploidentical) family members as donors, for the treatment of some blood cancers. NICE’s appraisal is being scheduled in line with a clinical trial that is expected to complete in 2020.